The tumor lysates of five TNBC patients (BC1-BC5) and four normal/benign tissues (N1-N4) showed similar differences in Smad2 and Smad3 protein expression levels in tumors vs normal/benign tissues (Figure 7E) as was noted in established cell lines (Figure 1). The gene discussed is SMAD3; the disease is neoplasm.